Gimferrer Laura, Campins Magda, Codina María Gema, Martín María Del Carmen, Fuentes Francisco, Esperalba Juliana, Bruguera Andreu, Vilca Luz María, Armadans Lluís, Pumarola Tomàs, Antón Andrés
Virology Unit, Microbiology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
Preventive Medicine and Epidemiology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
J Clin Virol. 2015 May;66:27-32. doi: 10.1016/j.jcv.2015.02.018. Epub 2015 Feb 26.
Human respiratory syncytial virus (HRSV) is the main cause of lower respiratory tract infections among infants and young children.
The molecular epidemiology and characterization of HRSV strains detected at a Spanish tertiary hospital during the 2013-2014 season is reported.
Phylogenetic analysis and molecular characterization of HRSV laboratory-confirmed respiratory samples were performed, based on coding sequences of G and F proteins.
HRSV infection was laboratory-confirmed in respiratory samples from 320 patients of which 223 (70%) were less than 2 years of age and none undergoing Palivizumab treatment. HRSV was detected at varying levels throughout the season with a maximum rate in the week 52/2013, right before the beginning of the influenza epidemic. Whilst both HRSV groups were found co-circulating, HRSV-B group clearly predominated. The phylogenetic analyses from 139 HVR-2 sequences revealed that most characterized strains belonged to ON1 and BA9 genotypes. Three different phylogenetic subgroups could be distinguished within these genotypes. In addition, three strains (out of the 52 randomly selected) were carrying amino acid substitutions in the epitope A of the F protein, one of them previously related to Palivizumab resistance.
The results of the present study highlight the importance of a continuous HRSV surveillance to monitor not only the introduction of new genotypes on circulation but also the emergence of viral variants with new genetic characteristics that can affect the antigenicity features and the susceptibility to the only current prophylaxis treatment and also for the future development of HRSV vaccines.
人呼吸道合胞病毒(HRSV)是婴幼儿下呼吸道感染的主要病因。
报告2013 - 2014年季节在一家西班牙三级医院检测到的HRSV毒株的分子流行病学及特征。
基于G和F蛋白的编码序列,对HRSV实验室确诊的呼吸道样本进行系统发育分析和分子特征鉴定。
在320例患者的呼吸道样本中实验室确诊为HRSV感染,其中223例(70%)年龄小于2岁,且均未接受帕利珠单抗治疗。整个季节均检测到不同水平的HRSV,在2013年第52周,即流感流行开始前达到最高检出率。虽然发现两种HRSV组同时流行,但HRSV - B组明显占主导。对139个HVR - 2序列的系统发育分析表明,大多数特征毒株属于ON1和BA9基因型。在这些基因型中可区分出三个不同的系统发育亚组。此外,在随机选择的52株中,有三株在F蛋白的表位A处携带氨基酸替换,其中一株先前与帕利珠单抗耐药有关。
本研究结果突出了持续进行HRSV监测的重要性,不仅要监测新基因型在流行中的引入情况,还要监测具有新遗传特征的病毒变体的出现,这些变体可能影响抗原性特征以及对目前唯一预防治疗的敏感性,也关乎HRSV疫苗的未来研发。